Home » Topics » Conferences

Conferences
RSS

Glaxo Wellcome/BioChem Pharma antitumor agent described at 211th ACS

April 19, 1996

YM-47813 revealed at 211th ACS

April 19, 1996

SNAP-5399 presented at 211th ACS

April 19, 1996

XQ-870, fibrinogen antagonist presented by DuPont Merck

April 19, 1996

SD-998, thrombin inhibitor

April 19, 1996

Yamanouchi selects YM-471 for clinical development

April 19, 1996

New ETA antagonist from SmithKline Beecham: SB-225757

April 19, 1996

EMD-94246, promising endothelin antagonist for hypertension

April 19, 1996

CMI-568, dual PAF antagonist and 5-LO inhibitor from CytoMed

April 19, 1996

Combined thrombolytic/neuroprotective agents more effective in treating stroke

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...